Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.29 Million USD | 82.41% |
| 2022 | -13.04 Million USD | -312.58% |
| 2021 | -3.16 Million USD | -537.89% |
| 2020 | -495.65 Thousand USD | -1080.51% |
| 2019 | -41.98 Thousand USD | 82.18% |
| 2018 | -235.6 Thousand USD | 93.95% |
| 2017 | -3.89 Million USD | -563.05% |
| 2016 | -587.13 Thousand USD | -14.59% |
| 2015 | -512.37 Thousand USD | 52.49% |
| 2014 | -1.07 Million USD | -45.43% |
| 2013 | -741.51 Thousand USD | -20.63% |
| 2012 | -614.68 Thousand USD | 54.7% |
| 2011 | -1.35 Million USD | 49.02% |
| 2010 | -2.66 Million USD | -71.36% |
| 2009 | -1.55 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -335.73 Thousand USD | 37.25% |
| 2024 Q2 | -71.69 Thousand USD | 78.64% |
| 2023 FY | -2.29 Million USD | 82.41% |
| 2023 Q1 | -760.02 Thousand USD | 20.71% |
| 2023 Q2 | -519.42 Thousand USD | 31.66% |
| 2023 Q3 | -479.64 Thousand USD | 7.66% |
| 2023 Q4 | -535.04 Thousand USD | -11.55% |
| 2022 Q3 | -7.38 Million USD | -1116.57% |
| 2022 FY | -13.04 Million USD | -312.58% |
| 2022 Q1 | -4.09 Million USD | -483.98% |
| 2022 Q2 | -606.79 Thousand USD | 85.19% |
| 2022 Q4 | -958.57 Thousand USD | 87.01% |
| 2021 Q2 | -416.87 Thousand USD | -61.88% |
| 2021 FY | -3.16 Million USD | -537.89% |
| 2021 Q3 | -207.95 Thousand USD | 50.12% |
| 2021 Q4 | -701.58 Thousand USD | -237.38% |
| 2021 Q1 | -257.51 Thousand USD | 18.6% |
| 2020 Q4 | -316.34 Thousand USD | -162.67% |
| 2020 FY | -495.65 Thousand USD | -1080.51% |
| 2020 Q3 | -120.43 Thousand USD | -186.62% |
| 2020 Q2 | -42.01 Thousand USD | -149.19% |
| 2020 Q1 | -16.86 Thousand USD | 57.1% |
| 2019 Q4 | -39.3 Thousand USD | 25.21% |
| 2019 Q1 | -33.95 Thousand USD | -217.54% |
| 2019 Q2 | -67.86 Thousand USD | -99.89% |
| 2019 Q3 | -52.56 Thousand USD | 22.55% |
| 2019 FY | -41.98 Thousand USD | 82.18% |
| 2018 Q3 | 166.72 Thousand USD | 170.99% |
| 2018 FY | -235.6 Thousand USD | 93.95% |
| 2018 Q4 | 28.88 Thousand USD | -82.67% |
| 2018 Q2 | -234.86 Thousand USD | -19.62% |
| 2018 Q1 | -196.34 Thousand USD | -539.5% |
| 2017 Q1 | -3.66 Million USD | -1563.99% |
| 2017 Q2 | -131.83 Thousand USD | 96.41% |
| 2017 Q3 | -61.62 Thousand USD | 53.25% |
| 2017 Q4 | -30.7 Thousand USD | 50.18% |
| 2017 FY | -3.89 Million USD | -563.05% |
| 2016 Q3 | -190.03 Thousand USD | -977.93% |
| 2016 Q4 | -220.48 Thousand USD | -16.02% |
| 2016 FY | -587.13 Thousand USD | -14.59% |
| 2016 Q1 | -158.98 Thousand USD | 35.83% |
| 2016 Q2 | -17.63 Thousand USD | 88.91% |
| 2015 Q1 | -5047.00 USD | -160.64% |
| 2015 Q2 | -81.52 Thousand USD | -1515.4% |
| 2015 Q3 | -178.03 Thousand USD | -118.37% |
| 2015 Q4 | -247.76 Thousand USD | -39.17% |
| 2015 FY | -512.37 Thousand USD | 52.49% |
| 2014 Q1 | 7110.00 USD | 101.78% |
| 2014 Q4 | 8323.00 USD | 112.97% |
| 2014 Q2 | -1.02 Million USD | -14581.36% |
| 2014 FY | -1.07 Million USD | -45.43% |
| 2014 Q3 | -64.17 Thousand USD | 93.77% |
| 2013 Q3 | -113.42 Thousand USD | -9.26% |
| 2013 Q2 | -103.81 Thousand USD | 51.7% |
| 2013 Q1 | -214.93 Thousand USD | -1982.47% |
| 2013 FY | -741.51 Thousand USD | -20.63% |
| 2013 Q4 | -399.41 Thousand USD | -252.13% |
| 2012 Q3 | -250.41 Thousand USD | -354.91% |
| 2012 Q2 | -55.04 Thousand USD | 81.58% |
| 2012 Q4 | -10.32 Thousand USD | 95.88% |
| 2012 FY | -614.68 Thousand USD | 54.7% |
| 2012 Q1 | -298.9 Thousand USD | -27.63% |
| 2011 Q4 | -234.2 Thousand USD | -67.22% |
| 2011 FY | -1.35 Million USD | 49.02% |
| 2011 Q3 | -140.06 Thousand USD | 78.15% |
| 2011 Q2 | -641 Thousand USD | -87.55% |
| 2011 Q1 | -341.76 Thousand USD | -23.84% |
| 2010 Q2 | -1.19 Million USD | -151.14% |
| 2010 FY | -2.66 Million USD | -71.36% |
| 2010 Q4 | -275.97 Thousand USD | 60.99% |
| 2010 Q3 | -707.38 Thousand USD | 41.04% |
| 2010 Q1 | -477.7 Thousand USD | -6.8% |
| 2009 Q1 | -283.59 Thousand USD | 0.0% |
| 2009 Q4 | -447.27 Thousand USD | -25.68% |
| 2009 Q2 | -358.26 Thousand USD | -26.33% |
| 2009 FY | -1.55 Million USD | 0.0% |
| 2009 Q3 | -355.89 Thousand USD | 0.66% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 297.054% |
| Ansell Limited | 129.3 Million USD | 101.774% |
| Ansell Limited | 129.3 Million USD | 101.774% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 107.368% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -43.77% |
| Psykey, Inc. | -797.5 Thousand USD | -187.665% |
| ConvaTec Group Plc | 262.7 Million USD | 100.873% |
| ConvaTec Group Plc | 262.7 Million USD | 100.873% |
| Encision Inc. | -640.78 Thousand USD | -258.022% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1517.757% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -1986.911% |
| Innovative MedTech Inc. | -4.27 Million USD | 46.324% |
| LifePoint, Inc. | -7.49 Million USD | 69.392% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 64.597% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 795.194% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -1766.825% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -390.958% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.049% |
| Sector 10, Inc. | -39.84 Thousand USD | -5657.808% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.718% |
| SheerVision, Inc. | 155.72 Thousand USD | 1573.191% |
| United Health Products, Inc. | -2.42 Million USD | 5.456% |
| Vasamed, Inc. | 4.74 Million USD | 148.376% |
| Yubo International Biotech Limited | -1.2 Million USD | -90.35% |